Decision AI · Strategy, Analytics and AI Teams

Decision AI for

Enterprise

Decision Infrastructure

Purpose-built for high-consequence enterprise decisions.

Grounded in causality, context, and memory - so every decision gets faster, sharper, and smarter than the last.

World Rank #2 in Enterprise Reasoning

Book a Demo
Signals
Reason
Decide
Track
Learn
Blindspot
Forecast
Stress test
Strategic
Operational
Execution
RCA
Competitive
Scenarios
Optimise
Tactical
Investment
Memory
DX
Detecting cross-functional signals
0signals detected
Pipeline velocity down 18%
CRM · last 14 days
Warn
NPS score up 12 pts (Q3→Q4)
Survey · last 30 days
+↑
Competitor price cut 12%
Market intel · this week
Watch
Scanning ERP, market feeds
Decision reasoning
Strategy lead
Why is pipeline slowing despite strong NPS? Should we push enterprise this quarter?
Pulling CRM pipeline and deal velocity data
Cross-referencing NPS signals with win rate
Assessing margin floor and capacity risk
DecisionX
Ask a follow-up question...
Decision
Accelerate enterprise
with margin and capacity guardrails
Primary actionTarget top-20 accounts
Margin floor32%
Capacity triggerOEE above 94%
Review cadence28-day checkpoint
Confidence
87%
Shared via
Email
Slack
Delivered
Track
Execution alignment & investment returns
Enterprise push on plan
92%
Top-20 account pipeline
+23%
Margin floor maintained
34%
28-day review signal
Due
+23%
Pipeline lift
87%
On-plan rate
Day 28
Review due
Enterprise push ↑23%
NPS causal: cycle length
Institutional memory
Decisions recorded
0
Patterns identified
0
Replication rate
0%

Powering 30,000+ Decisions

Trusted by Strategy & AI Teams

NVIDIA Inception Program Recognized by NVIDIA as an AI Startup to watch out for

Real World Decisions with Consequence

Months of deliberation. Minutes to decide. Causally. Contextually.

Each domain shows the operating model: the workflow, the inputs DecisionX connects, what the agent recommends, and the business outcome.

Move spend, inventory, and teams toward growth. For commercial teams that need to explain gaps, reallocate capital, and act before the quarter is gone, across CPG and Pharma.

Reconciliation

Reconcile ₹340 Cr of demand and margin into one trusted number before Q3 allocation

1 numberWatch

Flag 3 SKU-region pairs where sell-in and sell-out diverge more than 8%

Demand

Commit the Depot x SKU order with 94% of lines in confidence band

94% confidenceWatch

Flag 187 low-confidence lines for planner review

SKU & RCA

Region 3 decline traced to distribution, not demand

12 SKUsReduce

Cut the tail 12 SKUs running margin-negative for 3 quarters

Pricing & Assortment

Reprice 8 SKUs in Modern Trade as elasticity crosses the margin floor

8 SKUsScale

Hold assortment in 2 depots where shelf capacity is the binding constraint

Trade Spend

Reallocate ₹8 Cr to South & East for 2.3x incremental margin

2.3x marginScale

Shift MT / CSD mix to 60:40 as elasticity favours modern trade

Field Engagement

PHARMA

Prioritise 3 HCPs today at 3.2x uplift over list average

3.2x upliftScale

De-prioritise 40 HCPs with flat engagement this cycle

Media Mix

Move ₹16 Cr from TV to digital for 1.8x ROAS uplift

1.8x ROASScale

Accelerate the Q4 campaign as competitor spend drops

Every one of these decisions used to take weeks of context-stitching across data, tools, decks, and meetings, and the reasoning disappeared the moment it was made. Now it is captured, audited, and compounds into the next decision.

Prevent quality, yield, and downtime losses before they surface. For operations and quality teams that need to trace risk across inputs, process, equipment, and outcomes.

Scheduling

Resequence next week's run to absorb a 6-hour changeover without missing ship date

6 hrsWatch

Hold Line 2's SKU order as the current sequence is already optimal

Line Balancing

Rebalance 2 stations on Line 3 before the shift-end bottleneck repeats

2 stationsScale

Flag Station 4 as the recurring constraint across the last 3 shifts

Quality & Deviation

Escalate the Line 3 deviation requiring regulatory notification

RegulatoryWatch

Halt Batch 512 in-process as quality floor is not met

Asset Reliability

Schedule preventive maintenance on Line 1, signalled 48 hrs early

48 hrs earlyScale

Predict Line 1's bearing failure before the next unplanned stop

Yield & Waste

Change process parameter P4, traced to input variance

Param P4Reduce

Flag Supplier 2 CoA drifting from historical baseline

Make vs. Buy

Switch to Supplier 4 after a third cycle of elevated risk

3rd cycleWatch

Hold in-house production as the buy option's landed cost is now higher

Every one of these decisions used to take weeks of context-stitching across data, tools, decks, and meetings, and the reasoning disappeared the moment it was made. Now it is captured, audited, and compounds into the next decision.

Find the signal, choose the bet, and move faster. For scientific, medical, and innovation teams where each decision carries regulatory, portfolio, or time-to-market risk.

Discovery

Rank 3 lead candidates against portfolio budget before advancing one to preclinical

3 leadsScale

De-prioritise Candidate C as ADMET risk outweighs potency gain

Preclinical

Clear Compound Y's IND-enabling tox go/no-go ahead of the filing window

Go/no-goWatch

Hold Compound Z pending a repeat tox read on Finding 4

Clinical Trials

Open sites in Germany & Poland, enrolling 23% faster

23% fasterScale

Lock the 6-week visit schedule. 8 weeks lifts dropout 34%

Regulatory Filing

Sequence the EU filing ahead of the US as EMA review risk is lower this cycle

EU firstWatch

Flag Module 3 as the dossier's highest amendment risk

Pharmacovigilance

Escalate ICSR Case 4471 with the 15-day deadline at risk

15 daysWatch

Flag Drug X safety signal past the WHO-UMC threshold

Lifecycle

Advance Compound X to Phase 3 with thresholds met

Phase 3Scale

Drop programme Y as cost exceeds expected value

Every one of these decisions used to take weeks of context-stitching across data, tools, decks, and meetings, and the reasoning disappeared the moment it was made. Now it is captured, audited, and compounds into the next decision.

Every stage has a window. The shelf doesn't wait for the next one. For CPG innovation and brand teams making launch decisions against a fixed retail calendar, not a lab deadline.

Concept Screening

Fund 2 of 9 flavor concepts as the only pair clearing category-fit and margin thresholds

2 of 9Scale

Cut Concept F, margin potential falls below the portfolio floor

Demand Forecasting

Commit launch volume at 40K units as shelf capacity caps upside in 2 regions

40K unitsWatch

Flag North region as distribution-constrained ahead of launch

Formulation & Claims

Lock the reduced-sugar claim as the compliance review clears with no amendment

Claim clearedScale

Hold the "natural" claim pending one more lab verification cycle

Launch Readiness

Confirm the March scale-up date as supply and shelf timing now align

MarchWatch

Flag Depot 3 as 9 days behind the shelf-ready commitment

In-Market Diagnosis

Trace the flavor SKU's forecast miss to distribution, not demand, in 2 regions

2 regionsWatch

Rule out price as a cause, elasticity held steady through the miss

Scale / Reformulate

Reformulate over re-launch as-is, margin impact favours reformulation by 1.6x

1.6x marginScale

Discontinue the regional variant as neither path clears the margin floor

Every one of these decisions used to take weeks of context-stitching across data, tools, decks, and meetings, and the reasoning disappeared the moment it was made. Now it is captured, audited, and compounds into the next decision.

The Platform

The AI Decisioning Platform for all Scenarios.

DecisionX connects your data, domain knowledge, and decision history into a living causal model, then reasons through it to give you a decision, not just an answer.

Answer
Deep dive
Sources (237)
ShareExportSave
Conversation
Should we reallocate ₹50 Cr of trade investment? Where should we invest and why?
10:21 AM
DecisionX Agent
Analyzing enterprise context
Collecting signals
237 sources
Analyzing with 8 agents
Demand, Supply, Pricing, Finance, Risk, Channel, ROI
Causal reasoning
Building impact & trade-off models
Generating decision paths
Ranking and validating options
Analysis complete. Here is your decision.
Recommended Decision
Invest ₹8 Cr more in South & East regions
Projected to deliver highest incremental revenue with low risk and fastest time to impact.
Revenue Impact
+₹14.2 Cr
(+11.3%)
Margin Impact
+₹3.8 Cr
(+4.2%)
Risk Level
Low
vs. options
Time to Impact
Immediate
0–2 weeks
Why this recommendation
Demand momentum strongest in South & East
Competitor spends decreased in key markets
Inventory position healthy to support growth
ROI projected highest among all options
Aligned with annual growth and margin targets
Decision Paths (Trade-off Analysis)
Option A · Recommended92%
Invest in South & East
Revenue
+₹14.2 Cr
Margin
+₹3.8 Cr
Risk
Low
Time
Immediate
Option B78%
Invest in All Regions
Revenue
+₹8.1 Cr
Margin
+₹1.2 Cr
Risk
Medium
Time
2–4 wks
Option C64%
Maintain Current Split
Revenue
+₹4.3 Cr
Margin
+₹2.1 Cr
Risk
Low
Time
4–6 wks
Institutional judgment
that compounds.
Every decision made is captured with full reasoning, assumptions, and outcome. The system learns from every call, so the next decision is faster, better informed, and draws on everything that came before.
D1
Decision made & captured
Rationale, trade-offs, context, and confidence score stored in Decision Repository.
D+
Outcome tracked
Actual result measured against recommendation. Causal model updated with real-world feedback.
D2
Next decision informed by the last
New hires inherit institutional judgment. Same mistakes never repeated. Decisions accelerate.
∞
Compounding moat
The longer you use DecisionX, the sharper it gets. Competitors starting fresh can never catch up.
Decision Repository Outcome Tracking Institutional Memory Compounding Intelligence
Decision Agents.
Always on.
High-frequency decisions that can't wait for a weekly meeting. DecisionX agents monitor signals continuously, reason through your causal model, and act, or escalate, in real time.
Pharmacovigilance Agent
Monitors adverse event feeds, triages ICSRs, surfaces safety signals before regulators do.
Active · 24/7
Quality Deviation Agent
Traces raw material variance through production chain, flags QA risks before manufacturing.
Active · Real-time
Trade Spend Agent
Monitors channel performance, competitor signals, and ROI, reallocates spend automatically.
Active · Daily
Demand Signal Agent
Detects demand shifts early, surfaces reorder and reprioritisation decisions before stockouts.
Active · Real-time

The Architecture

The Core: Decision Ontology.
Self Learning & Causal.

DecisionX autonomously constructs a living Decision Ontology by connecting your Data, Domain, and Process ontologies into a single Causal State Graph.

Autonomously
01
Data Ontology

What exists, how it connects, and what it means

02
Process Ontology

How work flows and how outcomes are achieved

03
Domain Ontology

Industry rules, constraints, and business logic

Causal State Graph
Live · Self-learning
Data Ontology
Process Ontology
Domain Ontology
Output
Decision Ontology
Causal State Graph

A living model that continuously learns what decisions matter, what drives them, and why, across your entire enterprise.

Causal State Graph · live nodes
Trade Spend Demand Signal Competitor Activity Inventory Price Elasticity Seasonality Channel ROI
→Trade Spend causes Demand Uplift (+32%)
→Competitor Activity moderates Channel ROI
→Price Elasticity constrains Trade Spend ceiling
Zero hallucination Cross-functional Fully auditable Answers Why
Causal. Not Semantic.
Generic AI tools match patterns in text. DecisionX reasons through cause and effect, understanding why demand dropped, not just that it did. It traces the chain from raw material variance to batch failure, from competitor spend to channel erosion. Pattern matching gives you correlation. Causal reasoning gives you the answer.
Generic AI: semantic search & pattern match  •  DecisionX: causal reasoning
Self Learning. Always.
Every decision made sharpens the causal model. Every outcome tracked updates the ontology. DecisionX gets smarter with every decision your organisation makes, without manual retraining or knowledge management overhead. The system that learns is the system that compounds.

Real-World Proof

Decisions made. Outcomes delivered.

Not demos. Not projections. Production decisions running in CPG and Pharma enterprises today.

Pharma · R&D

Global Pharma Conglomerate

90%faster AE triage
Zeromissed 15-day deadlines
3×signals caught early

Millions of adverse event reports annually. Manual triage, missed signals, 15-day regulatory deadline pressure on every serious case.

Manufacturing · Quality

Leading Textile Manufacturer

60%quality defects prevented
48hrspredictive alert window
Liveraw → mfg causal chain

Quality failures traced to raw material variance, caught too late, post-production. No causal chain from input to defect.

Pharma OTC · Commercial

Global Pharma OTC Business

35%marketing efficiency gain
2×sales rep productivity
3 wksfaster campaign decisions

Marketing spend without channel-level ROI visibility. Campaign decisions on lag data. Sales teams unable to prioritise at scale.

Industries

Built for industries where
decisions carry cost.

DecisionX is specific enough for regulated, operational, and commercial contexts where a plausible answer is not enough. Each area below runs its own full decision lifecycle in depth on its own page, this is the summary.

Pharma

High-cost decision types

AE escalation Signal detection Launch sequencing Quality risk

A trial signal, a batch disposition, and a launch call are the same decision chain, not three separate reviews. DecisionX connects R&D, Manufacturing, and Commercial into one traceable story.

How one decision moves through all three functions

01

Pharma R&D Excellence

Adjudicates the trial signal against protocol and prior evidence.

Trial 3 shows an unexpected interaction with a common comorbidity medication.

02

Manufacturing Excellence

Adjudicates batch disposition under audit-ready evidence.

The affected lot is flagged for expanded stability testing before release.

03

Commercial Excellence

Ranks the HCP call list before launch messaging goes out.

HCP outreach is held on the affected indication while the stability read is pending.

DecisionX difference
A regulator or auditor can trace one decision across all three functions, not three separate logs that don't agree.
Explore the Pharma lifecycle
Consumer Packaged Goods

High-cost decision types

Trade allocation SKU prioritization Demand gap RCA Pricing response

A demand signal, a changeover decision, and a launch call are the same decision chain, not three separate meetings. DecisionX connects NPD, Manufacturing, and Commercial for CPG and FMCG brands into one traceable story.

How one decision moves through all three functions

01

New Product Development

Diagnoses why a launched SKU is under- or over-performing forecast.

A flavor SKU misses its launch forecast in two regions.

02

Manufacturing Excellence

Attributes yield loss to the process step where it occurs.

The same SKU's changeover loss is flagged as the line's top waste driver.

03

Commercial Excellence

Allocates the trade budget by incremental return, not history.

Reformulation is funded from the trade budget the changeover fix freed up.

DecisionX difference
Reformulation, changeover cost, and demand sit in one view, not three spreadsheets that don't add up.
Explore the CPG lifecycle
Manufacturing

High-cost decision types

Commodity hedge Make vs. buy Capacity reallocation Delivery commitment

A supplier delay, a line-capacity call, and a customer delivery commitment are the same decision chain, not three separate escalations. DecisionX connects Supply Chain, Plant Operations, and Order Fulfillment into one traceable story, across any manufacturing vertical.

How one decision moves through all three functions

01

Supply Chain & Procurement

Extends, holds, or unwinds a hedge position against live commodity exposure.

A key raw-material supplier flags an 11-day delay while the same commodity trends 8% up on the exchange.

02

Manufacturing Excellence

Decides make vs. buy inside a booking window that closes fast.

The affected line reprioritizes its schedule and evaluates a make-vs-buy call before the delay hits the floor.

03

Order Fulfillment & Delivery

Protects or renegotiates a delivery commitment before the ship date is missed.

The customer delivery commitment is protected with alternate sourcing or a renegotiated date.

DecisionX difference
Supplier risk, plant capacity, and delivery commitments sit in one view, not three trackers that don't agree.
Explore the Manufacturing lifecycle

Enterprise Trust

Built for decisions you must defend.

Explainable

Every answer traces to source, logic, assumptions and the full reasoning chain.

Human-in-the-loop

Ontology Agents build the model. Your team reviews, edits and governs before it reasons.

Secure

SOC 2 Type II, GDPR, ISO 27001. Public and private cloud. RBAC, IAM, SSO.

Compounding

Every tracked decision sharpens the ontology. Institutional intelligence that grows with use.

Decision intelligence platform

Stop assembling the picture.
Start deciding from it.

See DecisionX on your data, your context, your decisions. First value in 15 days.

Request a demo